Suzuki Yusuke

SUZUKI Yusuke, M.D., Ph.D.

Short Biography

Keywords

• IgA nephropathy
• Diabetic kidney disease (DKD)
• Hypertension
• Brain and cardio-renal connection
• End-stage renal disease (ESRD) and renal replacement therapy (RRT)

Main Research Topics and Interests

• Pathogenesis of IgA nephropathy and new diagnostic approach with pathogenesis-based biomarkers
• Development of disease modifying therapy for IgA nephropathy
• Uremic toxins-mediated vascular injury as a culprit for cardio-renal connection
• Evaluation of tumor necrosis factor receptor as a biomarker for DKD
• Roles of lipid mediators in kidney injury
• Medical economics study on RRT

Publications (in English, ～2021/7)

• Original Articles: 172
• Review Articles: 31
• Books: 3
• h-Index: 39 (Scopus)
• Sum of Times Cited: 5,784 (Scopus)

Recent Main Publications

• Makita Y, Suzuki H, Suzuki Y. TLR9 activation induces aberrant IgA glycosylation via APRIL-and IL-6-mediated pathways in IgA nephropathy. Kidney Int. 97(2)340-349,2020
• Gohda T, Kamei N, Koshida T, Kubota M, Tanaka K, Yamashita Y, Adachi E, Ichikawa S, Murakoshi M, Ueda S, Suzuki Y. Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease. J Diabetes Invest. 11(2):435-440,2020
• Takahata A, Arai S, Hiramoto E, Kitada K, Kato R, Makita Y, Suzuki H, Nakata J, Araki K, Miyazaki T, Suzuki Y. Crucial role of AIM/CD5L in the development of glomerular inflammation in IgA. J Am Soc Nephrol., 2020 (in press)
• More

Invited Lectures

• Suzuki Y: “Pathogenesis of IgAN and its clinical application.” 55th ANZSN online Annual Scientific Meeting, Australia, Nov 28-Dec 2, 2020(on line)
• Suzuki Y: “Novel therapies in IgA nephropathy.” 2020 Nephrology and Transplantation Update Course（55th ANZSN）, Australia, Nov 28-29, 2020(on line)
• Suzuki Y: “IgA nephropathy:Deciphering the relevant amidst the noise.” The ISN World Congress of Nephrology, Melbourne, Australia, Apr 12-15, 2019
• Suzuki Y: “Diabetic Kidney Disease and its management”. Airlangga University, Surabaya, Indonesia, May 12, 2018
• Suzuki Y: “IgA nephropathy: Novel biomarkers on Diagnosis and its clinical application”. Airlangga University, Surabaya, Indonesia, May 12, 2018
• Suzuki Y: “IgA nephropathy: Novel biomarkers on Diagnosis and its clinical application”. Indonesia University, Jakarta, Indonesia, May 9, 2018
• Suzuki Y: “Mucosal immune dysregulation and galactose-deficient IgA1 production in IgA nephropathy.” Korean Society of Nephropathy 2017. Seoul, Korea, May 18-21, 2017
• Suzuki Y: CME course “IgA nephropathy”. Sister Renal Center Program, Hanoi Medical University, Viet Duc Hospital, Hanoi, Vietnam, Oct 28- Nov 3, 2017
• Suzuki Y: “Tonsillar B cell activation via APRIL”. 14th International Symposium on IgA Nephropathy. Tours, France, Sep 15, 2016
• Suzuki Y: “Models mimicking the pathophysiology of IgAN”. ISN NEXUS Symposium. Berlin, Germany, April 16, 2016

Other Specific Comments

• Editorial board; Kidney International, Nephrology, Renal Replacement Therapy
• Liaison of Japanese Society of Nephrology (JSN) in JSN-Vietnam Viet Duc Hospital of Sister Renal Center Program (Global Outreach Program in International Society of Nephrology)
• Board member of International IgA nephropathy network
• Councilor of the International Society of Nephrology
• North East Asia regional Board Deputy Chair in International Society of Nephrology
• Executive Councilor of the of the Japan Society of Adult Diseases
• Executive Councilor of the of the Japanese Society of Nephrology
• Executive Councilor of the Japanese Society for the Study of Hypertension in Pregnancy
• Program Committee of the Executive Councilor of the International Society for the Study of Hypertension in Pregnancy 2020
• ISN Regional Board Deputy Chair (North and East Asia Region)
• ISN Regional Board Chair (North and East Asia Region)

Link